Seasonal fluctuations due to disease outbreaks and the timing of childcare center openings
First written in FY2022. 2 of 3 entries say "Restated". Latest entry: FY2026.
No other company in this theme has enough history to compare yet.
- FY2026RestatedAnnual report
「Dispensing revenue in the Group's pharmaceutical business accounts for more than 40% of total revenue. By its nature, dispensing revenue tends to be concentrated in periods when diseases such as influenza and hay fever are prevalent, and fluctuations in prescription volumes depending on the prevalence of these diseases could affect the Group's financial results.」
Reiterates the risk of seasonality in dispensing revenue due to disease outbreaks, together with its share of more than 40% of total revenue. - FY2025RestatedAnnual report
「Dispensing revenue in the Group's pharmaceutical business accounts for more than 40% of total revenue. By its nature, dispensing revenue tends to be concentrated in periods when diseases such as influenza and hay fever are prevalent, and fluctuations in prescription volumes depending on the prevalence of these diseases could affect the Group's financial results.」
Reiterates the risk of seasonality in dispensing revenue due to disease outbreaks, together with the figure showing that it accounts for more than 40% of total revenue. - FY2022First statedAnnual report
「Dispensing revenue in the Group's pharmaceutical business accounts for more than 45% of total revenue. By its nature, dispensing revenue tends to be concentrated in periods when diseases such as influenza and hay fever are prevalent, and fluctuations in prescription volumes depending on the prevalence of these diseases could affect the Group's financial results.」
Against the backdrop of dispensing revenue accounting for more than 45% of total revenue, identifies fluctuations in prescriptions due to disease outbreaks and the seasonality of expenses and subsidy income associated with childcare centres opening in April as risks.